𝔖 Bobbio Scriptorium

✦ LIBER ✦

A 7-month (MTH) safety update from the ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) trial: Anastrozole (A) maintains a beneficial side-effect profile compared with tamoxifen (T)

✍ Scribed by Anthony Howell

Book ID: 114315677
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 270 KB
Volume: 12
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(03)80153-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anastrozole has a protective effect on t

Anastrozole has a protective effect on the endometrium: data from the ATAC (‘Arimidex’, Tamoxifen, alone or in combination) trial

✍ S Duffy; M Greenwood 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 156 KB

The ATAC (‘Arimidex’, Tamoxifen, Alone o

The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) trial in postmenopausal women with early breast cancer—Updated efficacy results based on a median follow-up of 47 months

✍ Jack Cuzick 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

The ATAC ('Arimidex', Tamoxifen, Alone o

The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months

✍ Aman Buzdar 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 31 KB

0130 Initial adjuvant therapy with anast

0130 Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population

✍ A. Howell; J. Forbes; J. Cuzick 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Cost-effectiveness analysis of anastrozo

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

Anastrozole is safer and may be more eff

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10

✍ Hetty Carraway; Antonio C. Wolff 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB